Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00735514
What this trial is testing

Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerRadiation Toxicity+1 more
Case Comprehensive Cancer Center 83
Early research (Phase 1)Study completedNCT00884598
What this trial is testing

Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer

Who this might be right for
Brain and Central Nervous System TumorsLung Cancer
Universitätsmedizin Mannheim 19
Testing effectiveness (Phase 2)Study completedNCT03801304
What this trial is testing

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Brest 80
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Not applicableStudy completedNCT05034926
What this trial is testing

Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 212
Not applicableWithdrawnNCT01006226
What this trial is testing

64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Washington University School of Medicine
Early research (Phase 1)Ended earlyNCT00042835
What this trial is testing

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00003235
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 294
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT03218826
What this trial is testing

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT05633615
What this trial is testing

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaGrade 3b Follicular LymphomaPrimary Mediastinal (Thymic) Large B-Cell Lymphoma+4 more
SWOG Cancer Research Network 396
Not applicableUnknownNCT06310915
What this trial is testing

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IV
Guangzhou Institute of Respiratory Disease 30
Testing effectiveness (Phase 2)UnknownNCT01618474
What this trial is testing

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Who this might be right for
Stomach Cancer
Tianjin Medical University Cancer Institute and Hospital 100
Large-scale testing (Phase 3)Study completedNCT02560974
What this trial is testing

Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 1,035
Testing effectiveness (Phase 2)Study completedNCT04184921
What this trial is testing

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Who this might be right for
Lung Cancer Non-small Cell Stage IV
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 216
Testing effectiveness (Phase 2)Looking for participantsNCT05713006
What this trial is testing

Alectinib Pharmacokinetic in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBALK Gene Mutation
Instituto Nacional de Cancerologia de Mexico 45
Large-scale testing (Phase 3)Ended earlyNCT03300609
What this trial is testing

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

Who this might be right for
Colorectal AdenocarcinomaRAS Wild TypeStage III Colorectal Cancer AJCC v7+6 more
University of Southern California 4
Testing effectiveness (Phase 2)UnknownNCT04197687
What this trial is testing

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Who this might be right for
Breast AdenocarcinomaStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7+5 more
Academic and Community Cancer Research United 480
Testing effectiveness (Phase 2)Active Not RecruitingNCT04701307
What this trial is testing

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

Who this might be right for
Lung Small Cell CarcinomaNeuroendocrine CarcinomaStage III Lung Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 48
Large-scale testing (Phase 3)Looking for participantsNCT07155187
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 490
Next Page